Information is sourced from publicly available references. The information is for educational purpose of healthcare professionals and we are not liable for any loss or damage.
Indications/Uses
Hereditary transthyretin-mediated amyloidosis (hATTR amyloidosis) in adult patients w/ stage 1 or 2 polyneuropathy.
Dosage/Direction for Use
SCAdult w/ stage 1 or 2 polyneuropathyhATTR amyloidosis 25 mg once every 3 mth.